Hims vs MEDGm: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
53 providers verified independently·Independent researchHow we rank →

Short answer: Hims scores higher on our rubric, 5.9/10 against 2.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Hims beats MEDGm overall, scoring 5.9/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; MEDGm is from $179/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose MEDGm for shoppers who want a compounded glp-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named.

A side-by-side look at Hims and MEDGm to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for
Higher Rated

Hims

#42 of 53
5.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, and Zepbound paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.

Visit Hims

MEDGm

#53 of 53
2.7/10

MEDGm is a telehealth company selling compounded GLP-1 injections from $179/mo and dissolvable tablets from $249/mo, with brand-name Zepbound, Wegovy and Ozempic offered as a membership plus an unpublished medication cost. The compounded prices are readable before intake and the not-FDA-approved disclosure is prominent, which is more than several better-known programs manage. The gap is verification: no clinician, no pharmacy and no accreditation is named anywhere on the site or in its terms.

Visit MEDGm
FeatureHimsMEDGm
Why each oneThe only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 3.0 Trustpilot rating that lags peers.Publishes its compounded prices before intake and does not claim an accreditation it cannot support. Both are low bars that a surprising number of programs fail.
Our Score5.9/102.7/10
Headline Price$188 first month, then $298/mofrom $179/mo
Medication TypeBrandBoth
Insurance AcceptedNoNo
Best ForMen who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitorsShoppers who want a compounded GLP-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named.
Watch out forPending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.No medical director, prescribing clinician or medical group is named anywhere
Ranking#42#53
Get startedVisit HimsVisit MEDGm

Pros & Cons Compared

Hims

Pros

  • +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
  • +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
  • +Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
  • +Polished app and web experience, among the best user interfaces in men's telehealth.
  • +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.

Cons

  • Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
  • Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
  • 28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
  • Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
  • 'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Do not confuse its $69 price with the current brand-name GLP-1 menu.
  • The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
  • Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
  • Generic high-volume support, large patient base means less personalized attention than smaller competitors.

MEDGm

Pros

  • +Compounded prices visible on the landing page without starting an intake
  • +Prominent, correctly-worded disclosure that compounded GLP-1s are not FDA-approved
  • +Cancel any time, with a published refund policy rather than a buried one
  • +Claims no accreditation it cannot support, which is rarer than it should be
  • +HSA/FSA accepted; free shipping stated

Cons

  • No medical director, prescribing clinician or medical group is named anywhere
  • No compounding pharmacy is named; the terms promise a partner list that the terms do not contain
  • Brand-name Zepbound, Wegovy and Ozempic are priced as a membership plus an unpublished medication cost, so no brand total can be compared
  • No lab panel is offered or required at any tier
  • The homepage claims 120,000+ patients on a domain registered 2026-04-08; we could not reconcile the two
  • A prepaid contracted term is non-refundable, and dispensed medication is never refundable
  • No third-party rating exists that we could locate and verify

Our Verdict

Hims edges out MEDGm with a score of 5.9/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; MEDGm is from $179/mo. MEDGm offers both brand-name and compounded medications, giving you more flexibility.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both Hims and MEDGm start above the cheapest complete recurring program we track. Across all 53 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.

Try MEDGm

Headline price: from $179/mo

Visit MEDGm

Related comparisons

More head-to-head comparisons involving Hims and MEDGm.

Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Still working out whether either one is above board? We check that separately: is Hims legit, with the verification evidence behind each answer.